Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Sagimet Biosciences Inc shares valued at $598,115 were sold by Happel David on Jul 21 ’25. At $9.13 per share, Happel David sold 65,478 shares. The insider’s holdings dropped to 689,722 shares worth approximately $5.99 million following the completion of this transaction.
Also, Martins Eduardo Bruno sold 8,277 shares, netting a total of over 75,607 in proceeds. Following the sale of shares at $9.13 each, the insider now holds 106,936 shares.
Before that, Rozek Elizabeth had sold 10,780 shares from its account. In a trade valued at $98,471, the General Counsel and CCO traded Sagimet Biosciences Inc shares for $9.13 each. Upon closing the transaction, the insider’s holdings decreased to 10,780 shares, worth approximately $1.6 million.
As published in their initiating research note from Canaccord Genuity on July 24, 2025, Sagimet Biosciences Inc [SGMT] has been a Buy and the price target has been revised to $28. Analysts at Oppenheimer started covering the stock with ‘”an Outperform”‘ outlook in a report released in early December. As of November 12, 2024, UBS has initiated its “Buy” rating for SGMT. Earlier on June 28, 2024, Goldman downgraded its rating. Their new recommendation was “a Neutral” for SGMT stock which previously was a “a Buy”.
Analyzing SGMT Stock Performance
On last trading session, Sagimet Biosciences Inc [NASDAQ: SGMT] plunged -2.25% to $8.69. The stock’s lowest price that day was $8.6031, but it reached a high of $9.1881 in the same session. During the last five days, there has been a drop of approximately -14.80%. Over the course of the year, Sagimet Biosciences Inc shares have jumped approximately 159.40%. Shares of the company reached a 52-week high of $11.41 on 07/25/25 and a 52-week low of $1.73 on 04/07/25.
Support And Resistance Levels for Sagimet Biosciences Inc (SGMT)
According to the 24-hour chart, there is a support level at 8.47, which, if violated, would cause prices to drop to 8.24. In the upper region, resistance lies at 9.05. The next price resistance is at 9.41. RSI (Relative Strength Index) is 48.62 on the 14-day chart, showing neutral technical sentiment.
Is Sagimet Biosciences Inc subject to short interest?
Stocks of Sagimet Biosciences Inc saw a sharp steep in short interest on 2025-07-15 dropping by -0.43 million shares to 3.38 million. Data from Yahoo Finance shows that the short interest on 2025-06-13 was 3.81 million shares. A decline of -12.66% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 2.47 of the overall float, the days-to-cover ratio (short ratio) decline to 2.47.
Which companies own the most shares of Sagimet Biosciences Inc (SGMT)?
In terms of Sagimet Biosciences Inc share price expectations, FactSet research, analysts set an average price target of 6 in the next 12 months, down nearly -32.51% from the previous closing price of $8.89. Analysts anticipate Sagimet Biosciences Inc stock to reach 6 by 2025, with the lowest price target being 6. In spite of this, 5 analysts ranked Sagimet Biosciences Inc stock as Buy at the end of 2025. On May 02, 2024, H.C. Wainwright assigned a price target of “a Buy” to the stock and initiated coverage with a $32.
